Skip to main content
. 2020 Jan 10;9(1):184. doi: 10.3390/cells9010184

Figure 5.

Figure 5

Inhibitors of the FOXO1 protein and FOXO1 pathway. (A,B) Inhibitors of the FOXO1 protein. (C) Inhibitors of FoxO1-dependent glucose production without enhancing lipogenesis. (D) Entacapone suppressing FOXO1 protein expression through inhibiting fat mass and obesity-associated protein (FTO) enzymatic activity.